• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Commentary

  • Fri, 9/5/08 - 3:36pm
  • 0 Comments
  • 1867 reads
Author(s): 

Frank J. Criado, MD

Emergency Stent-graft Repair for Thoracic Aortic Injury by Castelli et al. is an important paper that lends further credence to the notion that endovascular repair is rapidly becoming the new standard of care in the treatment of traumatic transection of the thoracic aorta. The results herein reported, like many others, are exciting and very promising. They seem to ‘overshadow’ anything and everything that standard surgical repair has accomplished over the past several decades as serious operative morbidity and mortality rates have remained high.

Thoracic stent-graft technologies can still be described as “work-in-progress,” and this certainly resonates with this clinical application. Young individuals are often the victims in trauma events, and they frequently have small-diameter aortas. Most, if not all, currently available thoracic endografts are too large for many of these patients — a significant shortcoming that industry will hopefully overcome in the near future. Lower-profile devices are also needed to facilitate introduction and delivery on patients with small-size access vessels — females in particular. Finally, I’d like to say a word about the issue of left subclavian artery coverage by the device. It is true, of course, that exclusion of this vessel is often necessary in this context. But it is not (always) a safe and complication-free maneuver. If possible, and time permitting, I would strongly suggest ascertaining normal antegrade flow in the contralateral (right) vertebral artery and — if possible — the intactness of the circle of Willis by MRA imaging.

frank.criado@medstar.net

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
  • Robotic-Assisted Pci Procedures Using Corpath 200 System Will Be Discussed During CRT2012 Conference
    Tue, 02/07/12 - 10:00am
  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications